This report includes the IgA nephropathy pipeline analysis as of March 2018, to estimate and analyze the emerging therapies and their progress status in different phases of development. The report also contains competitive analysis and extensive information on monotherapies, targets and mechanism of action, and drug origin with relevance to IgA nephropathy. The report also includes epidemiology forecast for IgA Nephropathy for the period 2016 – 2025.
IgA Nephropathy Therapeutics Pipeline Analysis
By Molecule Type
By Route of Administration